Wider access to quality-assured rifapentine-based regimens is needed to accelerate tuberculosis prevention and care globally
Tiziana Masini, Avinash Kanchar, Fuad Mirzayev, Kerri Viney, Askar Yedilbayev, Matteo Zignol, Dennis Falzon
Source: Eur Respir J, 60 (2) 2201227; 10.1183/13993003.01227-2022
  
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Tiziana Masini, Avinash Kanchar, Fuad Mirzayev, Kerri Viney, Askar Yedilbayev, Matteo Zignol, Dennis Falzon. Wider access to quality-assured rifapentine-based regimens is needed to accelerate tuberculosis prevention and care globally. Eur Respir J, 60 (2) 2201227; 10.1183/13993003.01227-2022
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|